Literature DB >> 16359344

How do we define non-cardiac chest pain?

Udom Kachintorn1.   

Abstract

Noncardiac chest pain (NCCP) is a heterogeneous disorder associated with substantial health-care costs and resource utilization. NCCP is defined by recurrent episodes of substernal chest pain in patients lacking a cardiac cause after a comprehensive evaluation. The magnitude of the problem is quite high because of fear of serious or life-threatening heart diseases. Patients with chest pain who present for the first time to ambulatory care or to the emergency room, only 11% to 39% are ultimately diagnosed with coronary artery disease. The likely causes of NCCP are numerous and often overlap. Diagnosing NCCP is difficult because NCCP remains a diagnosis of exclusion that encompasses heterogeneous patient populations. First, cardiac ischemic must be excluded and coronary angiography remains the gold standard. Once cardiac causes have been ruled out, a diagnosis of NCCP is made. Mostly, the source for NCCP originates in essence from the esophagus. Gastroesophageal reflux disease (GERD) is the most common esophageal diseases present in patients with NCCP. An initial empiric trail of high-dose acid suppression is the most cost-effective measure in the management of these patients. When a diagnostic workup is chosen, it centers on upper gastrointestinal endoscopy, 24-hr esophageal pH monitoring and esophageal manometry.

Entities:  

Mesh:

Year:  2005        PMID: 16359344     DOI: 10.1111/j.1440-1746.2005.04164.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  10 in total

1.  Hypnosis for non-cardiac chest pain.

Authors:  O S Palsson; W E Whitehead
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

2.  Illness perceptions, negative emotions, and pain in patients with noncardiac chest pain.

Authors:  Jared I Israel; Kamila S White; Ernest V Gervino
Journal:  J Clin Psychol Med Settings       Date:  2015-03

3.  Non-cardiac Chest Pain and Anxiety: A Possible Link to Vitamin D and Calcium.

Authors:  Mohammad J Alkhatatbeh; Khalid K Abdul-Razzak; Noor A Amara; Mohamad Al-Jarrah
Journal:  J Clin Psychol Med Settings       Date:  2019-06

4.  Chest pain without established ischaemic heart disease in primary care patients: associated comorbidities and mortality.

Authors:  Ana Ruigómez; Elvira L Massó-González; Saga Johansson; Mari-Ann Wallander; Luis A García-Rodríguez
Journal:  Br J Gen Pract       Date:  2009-03       Impact factor: 5.386

5.  Habitual rapid food intake and ineffective esophageal motility.

Authors:  Kong-Ling Li; Ji-Hong Chen; Qian Zhang; Jan D Huizinga; Shawn Vadakepeedika; Yu-Rong Zhao; Wen-Zhen Yu; He-Sheng Luo
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

6.  Origin of and therapeutic approach to cardiac syndrome X: results of the proton pump inhibitor therapy for angina-like lingering pain trial (PITFALL trial).

Authors:  Christoph-G Dietrich; Susanne Laupichler; Sven Stanzel; Ron Winograd; Oliver Al-Taie; Carsten Gartung; Andreas Geier
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

7.  Low-dose amitriptyline combined with proton pump inhibitor for functional chest pain.

Authors:  Se Woo Park; Hyuk Lee; Hyun Jik Lee; Jun Chul Park; Sung Kwan Shin; Sang Kil Lee; Yong Chan Lee; Ji Eun Kim
Journal:  World J Gastroenterol       Date:  2013-08-14       Impact factor: 5.742

Review 8.  Recent advances in the management of chronic stable angina I: approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2010-08-09

9.  The high frequency of esophageal disorders in Iranian patients with non-cardiac chest pain.

Authors:  Saeed Abdi; Roghayeh Sahraie; Habib Malekpour; Sara Ashatri; Somayeh Jahani-Sherafat; Majid Iranshahi; Mojgan Frootan
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2018

10.  Association of 25-hydroxyvitamin D with HDL-cholesterol and other cardiovascular risk biomarkers in subjects with non-cardiac chest pain.

Authors:  Mohammad J Alkhatatbeh; Noor A Amara; Khalid K Abdul-Razzak
Journal:  Lipids Health Dis       Date:  2019-01-26       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.